From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves Gavreto for treatment of RET-positive, metastatic NSCLC

The FDA granted accelerated approval to pralsetinib for adults with metastatic RET fusion–positive non-small cell lung cancer detected by an FDA-approved test. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063